Lung disease: Man given one year to live after surprise diagnosis; what you need to know about IPF |

A deadly lung disease was discovered in a 68-year-old man during a routine check-up. What seemed…

Nerandomilast slows lung function decline in IPF, PPF Clinical trials

Nerandomilast, Boehringer Ingelheim’s investigational oral therapy, significantly slowed lung function decline in people with idiopathic pulmonary…

Nerandomilast (BI 1015550; Boehringer Ingelheim), an oral phosphodiesterase 4B (PDE4B) inhibitor, significantly slowed lung function decline…